You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,862,473


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,862,473
Title: Iontophoretic drug delivery device and reservoir and method of making same
Abstract:A reservoir electrode assembly of the present invention for an iontophoretic drug delivery device includes an electrode and a hydrophilic reservoir situated in electrically conductive relation to the electrode. The hydrophilic reservoir is formed from a bibulous hydrophilic cross-linked polymeric material having a first surface and a second surface that is adhesively adherent to the electrode. The first surface of the polymeric material is releasably adhesively adherent when applied to an area of a patient's skin. The polymeric material has a cohesive strength forms an adhesive bond with a bond strength between the second surface of the polymeric material to the electrode that is greater than the cohesive strength of the polymeric material. Additionally, an adhesive bond strength of the first surface of the polymeric material to the applied area of the patient is less than the cohesive strength of the polymeric material so that upon removal of the reservoir assembly of the invention from the applied area of the patient, substantially no polymeric material remains on the applied area and the hydrophilic reservoir remains substantially intact and adhesively adherent to the electrode.
Inventor(s): Keusch; Preston (Hazlet, NJ), Nrk; Vilambi (Jamaica Estates, NY), Eliash; Bruce Michael (Franklin Lakes, NJ)
Assignee: Vyteris, Inc. (Fair Lawn, NJ)
Application Number:10/085,428
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions for a specified period. The U.S. patent system, managed by the U.S. Patent and Trademark Office (USPTO), is complex and involves various aspects such as patent applications, claims, and the overall patent landscape. This article delves into the scope and claims of U.S. patents, using the example of U.S. Patent 6,862,473 to illustrate key concepts.

The Importance of Patents in Innovation

Patents play a crucial role in encouraging innovation by providing a temporary monopoly to inventors, allowing them to recoup their investment in research and development. The USPTO awarded 309,000 utility patents in 2018 alone, with businesses receiving the majority of these patents[1].

Patent Claims: The Heart of a Patent

Patent claims define the scope of protection granted by a patent. They are the legal boundaries that distinguish the invention from prior art and other inventions. The Patent Claims Research Dataset by the USPTO provides detailed information on claims from U.S. patents granted between 1976 and 2014, highlighting the complexity and variability of patent claims[3].

Types of Patent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a physical device or system.

The Patent Landscape: Technology Areas and Trends

The USPTO classifies patents into various technology areas, which helps in analyzing trends in patenting focus over time. For instance, electrical and mechanical engineering patents made up about 60% of USPTO patents in 2018, with a significant increase in electrical engineering patents driven by information and communication technologies (ICT)[1].

Broad Technology Areas

  • Electrical Engineering: Includes subclasses such as computer technology and digital communication.
  • Mechanical Engineering: Covers a wide range of mechanical inventions.
  • Chemistry and Instruments: Encompasses patents related to chemical processes and instruments.

Patent Eligibility: The Alice Test

The Supreme Court's decision in Alice Corp. v. CLS Bank International established a two-step test to determine whether patent claims are directed to patent-eligible subject matter. This test is crucial in ensuring that abstract ideas are not patented, which could stifle innovation[2].

Step One: Identifying Abstract Ideas

The court determines whether the claims are directed to an abstract idea. If they are, the inquiry proceeds to the second step.

Step Two: Transforming the Abstract Idea

The court assesses whether the claims include elements that transform the abstract idea into a patent-eligible application.

Case Study: U.S. Patent 6,862,473

To illustrate these concepts, let's consider U.S. Patent 6,862,473, though the specific details of this patent are not provided here. Here’s how the general principles apply:

Claim Construction

The claims of a patent like 6,862,473 would be carefully constructed to define the invention's scope. This involves identifying the independent and dependent claims, as well as any method or apparatus claims.

Technology Area

This patent would be classified under one of the broad technology areas, such as electrical engineering or mechanical engineering, depending on its subject matter.

Patent Eligibility

The claims of 6,862,473 would need to pass the Alice test to ensure they are directed to patent-eligible subject matter. This involves a detailed analysis of whether the claims are abstract ideas and whether they include elements that transform these ideas into something more concrete.

The Role of the USPTO

The USPTO plays a critical role in the patent process, from receiving and examining patent applications to granting patents. The office also provides datasets and research tools to help analyze patent trends and scope[3].

Patent Application Process

The process involves filing a patent application, which includes detailed descriptions of the invention and the claims. The USPTO then examines the application to determine whether the invention is novel, non-obvious, and useful.

Challenges and Considerations

Small Entities and Patent Costs

Small entities, defined as those with 500 or fewer employees, face significant challenges in the patent process due to high costs. There have been discussions about establishing a small claims patent court to address these issues[5].

Global Trends

Patent trends are not isolated to the U.S.; they are part of a global landscape. The WIPO classification system helps in comparing patent data internationally[1].

Probability of Receiving a U.S. Patent

The probability of receiving a U.S. patent varies based on several factors, including the technology field, the origin of the application, and whether the applicant is a large or small entity. Studies have shown that the overall allowance rate for utility patent applications is influenced by these factors[4].

Key Takeaways

  • Patent Claims: Define the scope of protection and are the legal boundaries of an invention.
  • Patent Eligibility: Must pass the Alice test to ensure the claims are directed to patent-eligible subject matter.
  • Technology Areas: Patents are classified into broad areas such as electrical and mechanical engineering.
  • USPTO Role: Critical in examining and granting patents, and providing datasets for analysis.
  • Challenges: Small entities face high costs, and there is a need for a small claims patent court.

FAQs

What is the primary purpose of patent claims?

Patent claims define the scope of protection granted by a patent, distinguishing the invention from prior art and other inventions.

How does the USPTO classify patents?

The USPTO classifies patents into broad technology areas such as electrical engineering, mechanical engineering, and chemistry, using the WIPO classification system.

What is the Alice test in patent law?

The Alice test is a two-step test developed by the Supreme Court to determine whether patent claims are directed to patent-eligible subject matter, ensuring that abstract ideas are not patented.

What challenges do small entities face in the patent process?

Small entities face high costs associated with the patent process, which can be a significant barrier to obtaining and enforcing patents.

How does the global patent landscape influence U.S. patents?

The global patent landscape, including international classifications and trends, influences U.S. patents by providing a broader context for innovation and competition.

Sources

  1. National Science Foundation. Invention: U.S. and Comparative Global Trends. January 15, 2020.
  2. United States Court of Appeals for the Federal Circuit. CONTOUR IP HOLDING LLC v. GOPRO, INC. September 9, 2024.
  3. United States Patent and Trademark Office. Patent Claims Research Dataset. August 28, 2017.
  4. Carley, Michael, Hegde, Deepak, and Marco, Alan. What Is the Probability of Receiving a US Patent? 2017.
  5. Administrative Conference of the United States. U.S. Patent Small Claims Court. 2022.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,862,473

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.